Titre : | Policies and incentives for promoting innovation in antibiotic research. : Politiques et incitations pour la promotion de l'innovation dans la recherche sur les antibiotiques. |
Auteurs : | E. MOSSIALOS ; S. EDWARDS ; et al. ; C.M. Morel |
Type de document : | Rapport |
Editeur : | Copenhague [DNK] : OMS Bureau régional de l'Europe, 2010 |
ISBN : | 978-92-890-4213-0 |
Description : | 224p. / tabl., fig., ann. |
Langues: | Anglais |
Mots-clés : | Médicament antibiotique ; Innovation médicale ; Pharmacorésistance ; Surveillance épidémiologique ; Infection ; Infection nosocomiale ; Mortalité ; Investissement ; Diagnostic ; Financement ; Coût maladie ; Dépense santé ; Consommation pharmaceutique ; Profession santé ; Pratique médicale ; Vaccination ; Recherche pharmaceutique ; Politique médicament ; Politique santé ; Etats Unis ; Europe ; OMS |
Résumé : | [BDSP. Notice produite par IRDES 8R0xmrm9. Diffusion soumise à autorisation]. High levels of pathogen resistance are, one-by-one, rendering current antibiotics obsolete. Coupled with insufficient investment in discovering new treatments, multidrug-resistant infections pose an increasingly urgent public health concern. To curb the growth of antibiotic resistance and prevent major morbidity and mortality from multidrug-resistant bacterial infections we must address overuse and actively promote research and development for antibiotics with novel mechanisms of action. This must be done through appropriately designed incentives for health and regulatory systems in addition to economic incentives to attract academic interest and industry investment. This book analyses many of the proposed policies and incentive mechanisms that are on the table and sheds light on the key issues that can help policy-makers reach informed, concrete decisions on how to avert this potential public health crisis (4ème de couv). |
Documents numériques (1)
En ligne URL |